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Abstract 
The most difficult clinical questions in stroke rehabilitation are “What is this patient’s 
potential for recovery?” and “What is the best rehabilitation strategy for this person, given 
her/his clinical profile?”  Without answers to these questions, clinicians struggle to make 
decisions regarding the content and focus of therapy, and researchers design studies that 
inadvertently mix participants who have a high likelihood of responding with those who do 
not. Developing and implementing biomarkers that distinguish patient subgroups will help 
address these issues and unravel the factors important to the recovery process. The goal of the 
present paper is to provide a consensus statement regarding the current state of the evidence 
for stroke recovery biomarkers. Biomarkers of motor, somatosensory, cognitive and language 
domains across the recovery timeline post-stroke are considered; with focus on brain 
structure and function, and exclusion of blood markers and genetics. We provide evidence for 
biomarkers that are considered ready to be included in clinical trials, as well as others that are 
promising but not ready and so represent a developmental priority. We conclude with an 
example that illustrates the utility of biomarkers in recovery and rehabilitation research; 
demonstrating how the inclusion of a biomarker may enhance future clinical trials. In this 
way, we propose a way forward for when and where we can include biomarkers to advance 
the efficacy of the practice of, and research into, rehabilitation and recovery after stroke. 
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Introduction  
Stroke is a heterogeneous condition, making choice of treatment, and prediction of 
outcome and treatment response, difficult. Despite this, clinical trials are often designed with 
a 'one size fits all' point of view, which can make them vulnerable to patient heterogeneity, 
reduced statistical power, and thus failure. Biomarkers can greatly inform patient selection 
for trials in general medical research, and this is equally true for stroke recovery. A stroke 
recovery biomarker (SRB) can be defined as an indicator of disease state that can be used as a 
measure of underlying molecular/cellular processes that may be difficult to measure directly 
in humans, and could be used to understand outcome, or predict recovery or treatment 
response (1).  
In practical terms biomarkers should improve our ability to predict long-term 
outcomes after stroke across multiple domains. This is beneficial for: a) patients, caregivers 
and clinicians; b) planning subsequent clinical pathways and goal setting; and c) identifying 
whom and when to target, and in some instances at which dose, with interventions for 
promoting stroke recovery (2). This last point is particularly important as methods for 
accurate prediction of long-term outcome would allow clinical trials of restorative and 
rehabilitation interventions to be stratified based on the potential for neurobiological recovery 
in a way that is currently not possible when trials are performed in the absence of valid 
biomarkers. Unpredicable outcomes after stroke, particularly in those who present with the 
most severe impairment (3) mean that clinical trials of rehabilitation interventions need 
hundreds of patients to be appropriately powered. Use of biomarkers would allow 
incorporation of accurate information about the underlying impairment, and thus the size of 
these intervention trials could be considerably reduced (4), with obvious benefits. These 
principles are no different in the context of stroke recovery as compared to general medical 
research (5). 
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Interventions fall into two broad mechanistic categories: 1) behavioural interventions 
that take advantage of experience and learning-dependent plasticity (e.g. motor, sensory, 
cognitive, and speech and language therapy), and 2) treatments that enhance the potential for 
experience and learning-dependent plasticity to maximise the effects of behavioural 
interventions (e.g. pharmacotherapy or non-invasive brain stimulation) (6). To identify in 
whom and when to intervene, we need biomarkers that reflect the underlying biological 
mechanisms being targeted therapeutically. 
Our goal is to provide a consensus statement regarding the evidence for stroke 
recovery biomarkers that are helpful in outcome prediction and therefore identifying 
subgroups for stratification to be used in trials (7). We focused on stroke recovery biomarkers 
that can investigate the structure or function of the brain (Table 1). Four functional domains 
(motor, somatosensation, cognition, and language [Table 2]) were considered according to 
recovery phase post stroke (hyperacute: <24hrs; acute: 1 to 7 days; early subacute: 1 week to 
3 months; late subacute: 3 months to 6 months; chronic: > 6 months (8)). For each functional 
domain, we provide recommendations for biomarkers that either are: 1) ready to guide 
stratification of subgroups of patients for clinical trials and/or to predict outcome, or 2) are a 
developmental priority (Table 3). Finally, we provide an example of how inclusion of a 
clinical trial-ready biomarker might have benefitted a recent phase III trial. As there is 
generally limited evidence at this time for blood or genetic biomarkers, we do not discuss 
these, but recommend they are a developmental priority (9-12). We also recognize that many 
other functional domains exist, but focus here on the four that have the most developed 
science. 
A challenge across the reviewed literature was to determine where biomarker data 
explained recovery beyond that denoted by clinical outcome measures, such as the 
proportional recovery rule that has been demonstrated using motor (3, 13), visuospatial 
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neglect (14) and language (15) outcomes. Given the recency of these models, we were unable 
to address this in this paper and urge people to consider this in their future trial design. 
Further, to fully understand the predictive capacity of biomarkers we need to move beyond 
cross-sectional studies, which constitute the bulk of the biomarker literature at present, and 
conduct mechanistic studies that go beyond simple correlations, as well as conduct 
longitudinal studies that provide data useful for predicting outcome or treatment response. 
 
Motor 
Neuroimaging biomarkers include quantitative characterisation of the stroke lesion 
itself, as well as the structure and function of non-lesioned brain areas. There is little 
consensus regarding the usefulness of characterizing the ischemic penumbra at the hyper-
acute stage in relation to predicting motor outcomes. Recent data suggest that the site of 
ischemic penumbra, rather than volume, could predict outcome or treatment response (i.e. to 
thrombolysis) and affect motor recovery (16). Acute infarct volume correlates with motor 
outcome (National Institute of Health Stroke Severity [NIHSS]), but this relationship is 
attenuated with increasing leukoaraiosis severity (17, 18). The extent of existing white matter 
disease (i.e. leukoaraiosis) has been associated with acute lesion size, degree of lesion 
expansion and stroke severity indicated by initial NIHSS score (19). These findings 
underscore the point that biomarker performance varies across different stroke subgroups.  
Measures of corticospinal tract (CST) white matter integrity in the acute stage may 
predict motor outcome. Early measurement of CST fiber number via diffusion tensor imaging 
(DTI), a reflection of white matter integrity, predicts motor outcome (Fugl-Meyer score) at 
12 months, especially for patients with initially more severe impairment (20). Other data (21), 
though not all (22), also suggest that fractional anisotropy (FA) of the ipsilesional and 
contralesional CST at the acute stage is higher in individuals who achieve better motor 
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recovery after stroke. Data also support the potential utility of the asymmetry between the 
ipsilesional and contralesional CST FA to predict treatment gains in the chronic stage (23). 
Measures of the extent of CST injury in the acute stage, such as via corticospinal tract 
lesion load (24), also have predictive value for poor motor outcome. A model including this 
biomarker improved prediction of Fugl-Meyer motor score at 3 months post-stroke that was 
beyond what could be determined by baseline behavioral assessment, age or infarct volume. 
Several studies have found that in the chronic stage the extent of CST injury also helps 
predict treatment gains (25-27). 
Other regions distant from the lesion influence motor recovery. While measures 
related to distant regions require further development to reach the stage of valid biomarker, 
several useful observations have been published in the chronic stage, including those related 
to contralesional CST (28), corpus callosum (29), precentral gyral (30), and superior 
longitudinal fasciculi (31, 32). Multivariate machine learning methods have recently been 
applied to neuroimaging data with the aim of providing individual predictions based on an 
approach that integrates features extracted from brain voxels from multiple brain areas, rather 
than one area (33). In patients presenting with severe upper limb impairment, classification of 
a subsequent good or poor recovery was more accurate using lesion information from a range 
of cortical and subcortical motor-related regions compared to just using CST (87% compared 
to 73% accuracy respectively) (34). Such approaches emphasize the importance of taking 
account of damage in multiple brain regions, extending beyond CST, in order to better 
understand variation in motor outcome (34-36). 
There is broad consensus that the presence of an upper limb motor evoked potential 
(MEP) in response to transcranial magnetic stimulation (TMS) at the hyperacute and acute 
stages strongly predicts good motor outcome (37, 38) and that shorter motor evoked potential 
(MEP) latencies and central motor conduction times are associated with better outcome (39). 
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The presence of a MEP has been found to identify which patients will follow the proportional 
recovery rule (40). Similarly, in the leg, the presence of a MEP indicates that an individual is 
more likely to be independently mobile 12 months post-stroke (41-43), yet this measure does 
not relate to walking recovery (13). Prediction of recovery is more challenging for patients 
without a MEP (40, 44) and combining TMS with MRI biomarkers may be useful in this 
context (38) TMS at the chronic stage helps explain the relationship between corticomotor 
function and motor performance in cross-sectional studies, and those who have a MEP are 
more likely to benefit from physical interventions (23, 45, 46). 
Resting state functional connectivity (rsFC) findings in the early and late subacute 
phases converge on the conclusion that interhemispheric connectivity is of particular 
importance to motor control. Cross-sectional studies have demonstrated decreased rsFC 
correlates with the degree of motor impairment (47, 48). The are positive associations 
between acute/early subacute rsFC (ipsilesional primary motor cortex [M1] to 
contralesional thalamus, supplementary motor area [SMA], and medial frontal gyrus) and 
motor outcomes at 6-months (Fugl-Meyer score) (49). In late subacute patients, the amount 
of CST damage combined with interhemispheric M1 rsFC best predicted therapy-induced 
gains (27). Fan et al. (50), found that in late subacute patients change in interhemispheric 
M1-M1 rsFC predicts improvements in the Wolf Motor Function Test. Results from a ridge 
regression machine-learning algorithm analysis of a large sample of early subacute stroke 
patients suggest that rsFC may explain a smaller amount of the behavioral variance observed 
than the amount of structural damage to the CST (51). As rsFC can be performed in patients 
with severe deficits after stroke and can interrogate all brain networks simultaneously, it 
represents a priority for development. 
Quantitative indices extracted from functional MRI (fMRI) in the early and late 
subacute stage, such as the laterality index from M1, and the study of its change over time, 
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show that stroke is associated with a less lateralized pattern of activation as compared to 
healthy subjects, a finding that is exaggerated among patients with poorer outcomes (52, 53). 
One unifying conclusion across studies is that the best motor outcomes are associated with 
the greatest shift towards the normal state of brain function (54). The laterality index has been 
used as a judgment criterion of efficacy in the chronic stage in trials testing mirror therapy 
(55), constraint-induced therapy (56) and robotic intervention protocols (57), and can predict 
treatment response (58). Other fMRI metrics such as activation volume (59, 60) or percent 
signal change (61) within key motor network nodes can predict response to treatment in the 
chronic stage. As there are fewer long-term studies of the laterality index, and it often shows 
significant biological associations, this is an area of priority for development. 
Magnetoencephalography (MEG) or electroencephalography (EEG), non-invasive 
measures of cortical neuronal oscillations, are sensitive to alterations in both GABAergic and 
glutamatergic signalling that are important for plasticity and recovery after stroke (62-64). 
Changes in cortical excitation and inhibition represent novel therapeutic targets, but cannot 
be measured directly in humans. Stroke patients with poorer outcomes have persistent, 
increased low-frequency oscillations at the acute, and early/late subacute stages (65); 
suggesting predominant inhibitory mechanisms in the peri-lesional cortex. Acutely, lower 
beta-rebound in response to tactile finger stimulation (which indicates increased early post-
stroke sensorimotor excitability) (66) and increased somatosensory map size (67) predict 
good recovery after stroke. Also, in a single stroke patient, zolpidem reversed increased peri-
lesional theta (4-10Hz) and beta oscillations leading to clinical improvement (68). In the 
chronic phase, dense array EEG was able to predict motor gains from a 4-week intensive 
training program (69). While MEG/EEG cannot currently be recommended to guide 
subgroup stratification in trials at present, this is a developmental priority. 
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Combining neuroimaging and neurophysiology biomarkers may be useful for 
predicting motor outcomes and therapy response (70). Upper limb outcomes at 3-months can 
be predicted at the early sub-acute stage by measuring first clinical, then TMS and finally 
MRI biomarkers in a stepdown approach, as in the PREP algorithm (71, 72). Stoykov & 
Stinear (73) treated chronic stroke patients using active-passive bilateral arm training and 
discovered that fractional anisotropy asymmetry between the two CST tracts accounted for 
40% variability in clinical improvement. Factoring in whether patients were MEP+/- 
improved the predictive model. One recent study emphasized that combining neuroimaging 
measures of neural injury and neural function was key to best predicting response to a 
standardized robotic therapy in the chronic stage (27).  
In summary, neuroimaging and neurophysiology CST biomarkers can predict motor 
outcome and response to therapy after stroke, and are recommended for use in clinical trials, 
e.g., for stratifying patients. The evidence for rsFC, fMRI and MEG/EEG biomarkers are 
promising and are developmental priority areas (Table 4A).  
 
Somatosensory 
Currently there are few studies of structural or functional biomarkers conducted to 
understand outcome, predict recovery or predict treatment response in the somatosensory 
functioning domain in the hyperacute or acute phases post-stroke. Most work on structural 
biomarkers involving the non-lesioned brain has focused on understanding outcome by 
mapping the structural integrity of residual pathways. Feasibility of visualisation of 
sensorimotor systems by tracking fibres has been demonstrated in hyperacute, acute and 
early subacute phases for somatosensory symptoms (74). There are changes in morphology 
of the somatosensory cortex of chronic stroke patients (75), with co-localized structural 
(cortical thickness) and functional (brain activation, tactile stimulation) effects. Only one 
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study noted associations between the structure of somatosensory regions and motor outcome 
in the chronic phase (76). 
Failure to activate the somatosensory cortex during median nerve stimulation in the 
acute stage predicts poor clinical recovery at 3 months (77). Using MEG, reduction in 
interhemispheric asymmetries of activity at chronic compared to acute phases was 
associated with a worse clinical state (78). Studies using MEG in early and late subacute 
phases show that changes in source strength of the primary somatosensory cortices correlate 
with the extent of recovery of sensorimotor functions as determined by neurological exams 
(e.g., graphesthesia test) (79). Yet, MEG can be complicated to employ, and so broader 
evaluation of these findings might benefit from use of less complex electrophysiological 
methods such as EEG. In the subacute phase differences in brain activity measured with 
task-related fMRI correlated with touch impairment in patients with thalamus /internal 
capsule lesions compared to those with lesions of primary (SI) or secondary (SII) 
somatosensory cortex (80). Similarly, responsiveness of SI at 1-15 days post-stroke is 
associated with improvement of two-point discrimination 3 months post-stroke (81). Resting-
state FC studies of touch impairment and recovery in the chronic phase demonstrated a 
correlation between changes in connectivity from contralesio al SII and contralesional 
inferior parietal and middle temporal gyrus with changes in a tactile discrimination score that 
were absent in a control group (82). 
Associations are observed between somatosensory function (using the Hand Active 
Sensation Test) and a left/right FA ratio from the sensory component of the superior thalamic 
radiation in the chronic stage (83) and the frontoparietal tracts in the acute (84) and chronic 
(85) phases. In addition, somatosensation function in the chronic phase correlates with 
activity in the ipsilesional and contralesional primary sensorimotor cortex (86) and a more 
distributed pattern of activity involving parietal cortex (83). Improvement in touch 
Page 11 of 38 International Journal of Stroke
For Review Only
 12
discrimination at 6 months was associated with increased rsFC between seeds in the 
contralesional hemisphere and distributed regions, including cerebellum (82). Using MEG, 
involvement of ipsilesional primary hand representation areas positively contributed to 
clinical recovery (87). 
Changes have also been reported in association with training of touch discrimination 
(88), passive proprioception (89) and sensorimotor function (90), with a focus on tracking 
outcomes and mechanisms, rather than prediction. For example, touch discrimination training 
of patients with somatosensory loss in the chronic stage post-stroke was associated with 
different patterns of change in activation with thalamic/capsular compared to SI/SII cortical 
lesion (88). This area of research is a priority for development.  
There is insufficient evidence to recommend the use of any specific biomarkers of 
somatosensory system function in clinical trials, however, several candidates are suggested. 
The recovery of somatosensation is often overlooked despite well-documented observations 
that impaired sensation is an impediment to optimal recovery (91-93). Functional biomarkers, 
including task-related activation and rsFC are a developmental priority (Table 4B).  
 
Cognition 
Mapping executive/cognitive functions to specific brain regions is problematic 
because these functions are distributed widely across broad brain networks, and their 
relationships are complex. Indeed, studies that readily identify structure-function 
relationships for phonology and semantic processing, and often fail to find an equivalent for 
executive function (94). The most consistent relationships were found in white matter. 
Frontal and basal ganglia region microbleeds were associated with executive dysfunction 
outcome in the chronic phase (95), and another study found that mean diffusivity of normal 
appearing white matter (whole brain) in non-lesioned areas correlated with outcomes for 
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executive function among individuals with ischaemic leukoaraiosis (plus a previous lacunar 
stroke) (96, 97). EEG changes in frontal lobes paralleled behavioral gains across multiple 
cognitive domains in one study that used intensive video gaming in health adults (98); the 
same may extend to patients with stroke.  
Though functional imaging methods may offer the best hope of generating robust 
biomarkers for executive function, there is little published work. Available associations are 
correlative and from cross-sectional studies, rather than predictions of outcomes or more 
complex evaluation of biological hypotheses. In the late subacute phase, executive 
functioning correlates with alpha band functional connectivity between the left fronto-
opercular cortex and the rest of the brain (99). Yet, it is possible that the task-dependent 
changes observed with functional imaging data have less to do with new domain-specific 
areas being generated, and more to do with cognitive control networks improving residual 
performance (100). In individuals with chronic post-stroke aphasia a positive correlation 
between task-dependent activity in midline frontal cortex and language recovery was 
interpreted as reflecting domain-general cognitive control systems (101), a finding that is 
consistent with training effects in healthy elderly subjects (98). Development of biomarkers 
in this context would likely foster advances in therapeutic techniques to train executive 
function, a key priority that is feasible (102).  
The default mode network (DMN) has emerged as a key biological substrate in the 
context of cognitive functioning (103). Studies in the subacute and early chronic phases 
report altered rsFC in the DMN correlated with cognitive performance after stroke (104-107) 
Re-emergence of the anticorrelation between the DMN and task-positive networks, such as 
the dorsal attention network (DAN) (108), is associated with behavioural recovery of 
cognitive functions. Resting state studies have provided robust examples of disruption of 
interhemispheric connectivity associated with domain-specific cognitive deficits (47, 51, 109, 
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110) and recovery (111). In a small longitudinal study of stroke patients compared to healthy 
controls, He at al (2007) showed a robust correlation between left-right posterior intraparietal 
sulcus rsFC and accuracy of detection of targets presented in the left neglected visual field.  
Multiple studies have confirmed this connectivity is much depressed in the acute stage after 
stroke in persons with USN and returns toward normal in association with the resolution of 
symptoms, with the largest current longitudinal study retaining 64 stroke patients at 12 
months (111). Similar relationships have been reported for the DMN and other networks (47, 
51, 109, 110). While correlational analyses cannot establish causality and do not provide the 
predictive functions required of an effective stroke recovery biomarker, the finding that a 
change in rsFC correlates with behaviour lends support to the idea that measures of network 
connectivity have the potential to serve as useful biomarkers across multiple behavioural 
domains, a possibility that requires further studies.  
In the domain of spatial cognition, multiple moderately sized studies of right 
hemisphere injury confirm that damage to different major long range white matter tracts may 
predict chronic persistence of unilateral spatial neglect.  Two well designed longitudinal 
studies implicate the inferior occipitofrontal fasciculus and uncinate fasciculus (112) and 
decreased FA in the left and right superior longitudinal fasciculus II, and forceps major of the 
corpus callosum with neglect scores. In cross-sectional studies, linear regression shows an 
association of unilateral spatial neglect with damage to the fronto-parietal segment of the 
arcuate fasciculus, and that 78.9% and 81.6% of patients with neglect had damage to the 
superior longitudinal fasciculus II and superior longitudinal fasciculus III respectively 
compared to only 15% and 30% in patients without neglect (113). While damage to superior 
longitudinal fasciculus III, arcuate fasciculus, frontal aslant, and frontal inferior longitudinal 
fasciculus are increasingly implicated in abnormal spatial cognition (114). Whether damage 
to any of these white matter structures as measured in the acute phase of stroke can serve as a 
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biomarker for persistence of USN in the chronic phase, or in stratifying or selecting patients 
for interventions is yet to be determined. 
Based on this evidence, biomarkers of cognitive function, including executive 
functioning, are not ready for immediate broad implementation in clinical trials. Thus, further 
study and validation of biomarkers that explain current state and future chante in cognitive 
functions are a significant priority area for development. Resting state FC is a promising 
candidate biomarker (Table 4C), and study of its utility as a biomarker of recovery is 
emphasized here.  
 
Language 
There are a number of studies identifying a relationship between lesion site and 
aphasia (115), anatomical findings that suggest potential metrics to evaluate as biomarkers. In 
the hyperacute period, perfusion-weighted MRI showed that word comprehension deficits 
are strongly correlated with blood flow within Wernicke’s area (116). A related study 
demonstrated that lexical processing was more strongly related to the volume of hypo-
perfused tissue than the volume of lesion (117). Imaging illustrates that recovery of word 
comprehension from the hyperacute to acute phase (3 days) is associated with reperfusion of 
Wernicke’s area (118). Recovery of naming in the hyperacute period is predicted by 
reperfusion of left posterior middle temporal/fusiform gyrus, Broca’s area, and/or Wernicke’s 
area (119-121). There are no established predictors of long-term (>3-days) recovery from 
biomarkers assessed in the hyperacute period (<24 hours); thus, this is a developmental 
priority. 
Impaired repetition in the acute phase was associated with structural damage to the 
arcuate fasciculus and Broca’s area as well as tissue dysfunction (hypoperfusion and frank 
damage) in the inferior portion of the left supramarginal gyrus and temporal-parietal junction 
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(122). Kummerer et al., (123) also observed that impaired repetition at this phase was 
associated with posterior temporal-parietal lesions and damage to the dorsal superior 
longitudinal and arcuate fasciculus, while comprehension deficits were associated with 
ventral extreme capsule fibre damage. Measures of functional connectivity may also be 
useful in this phase, as a recent study of acute lacunar stroke patients observed that increased 
resting state FC between the left and right superior temporal gyri was correlated with poorer 
language function (124). 
In the early subacute phase, there are relationships between lesion location and 
aphasia symptoms that suggest potential biomarkers. Kriesler et al. (125) correctly classified 
67% to 94% of patients based on analysis of lesion location and symptoms. Forkel et al., 
(126) demonstrated prediction of recovery at 6 months was improved by adding volume of 
the left long segment of the arcuate fasciculus to a regression model including age, sex, and 
lesion size; including volume of the right long segment of the arcuate fasciculus further 
improved recovery prediction. Recent work by Geranmayeh et al., (127) showed that 
propositional language production is predicted by interactions between brain networks 
(DMN, fronto-temporo-parietal, and cingulo-opercular networks) rather than by activity 
within a single individual network highlighting the distributed nature of language operations. 
Functional MRI activity in the early subacute phase shows promise as a predictor of long-
term recovery when analyzed using a multivariate machine learning technique. Saur et al., 
(128) employed this method with a mask of task-induced fMRI activity in bilateral frontal 
and temporal regions in combination with behavioural language performance and age. This 
approach correctly predicted good versus poor language recovery in 86% of individuals with 
stroke who had aphasia at 2 weeks. In the largest case-control study of subacute stroke 
patients with aphasia to date, Yang et al (124) found that in patients with lacunar stroke, 
interhemispheric rsFC was increased in the superior temporal gyrus, the inferior frontal gyrus 
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and the lingual gyrus. Of note is the observation that the interhemispheric hyperconnectivity 
of the superior temporal gyrus was inversely correlated with the aphasia quotient, indicating 
that greater connectivity was associated with worse aphasia. 
Voxel-based analyses in the chronic phase has established utility in multiple brain 
systems and specifically have identified structural damage associated with particular aphasic 
symptoms, distinguishing between semantic and phonological processes and recognition 
versus production (129-131). Arcuate fasciculus lesion load negatively influences speech 
production (132) and classifies severe and non-severe outcomes with 90% accuracy for 
naming and 96% accuracy for speech fluency (133). The PLORAS (Predicting Language 
Outcome and Recovery After Stroke) system (134) uses a Gaussian process model regression 
with a large database of stroke patients (from 1 month post, therefore covering early and late 
subacute, and chronic phases) with structural MRI, demographic, and language performance 
to provide predictions of aphasia recovery at the individual level. Using this approach and 
covariate factors of time of stroke, volume, and 35 different brain regions, predictions of 
language outcome, and within subject changes in speech production, have been identified 
(135). This method has high potential to provide measures that can serve as biomarkers to 
predict recovery. 
Posterior middle temporal lobe damage can negatively affect aphasia therapy outcome 
in the chronic phase (122). Meinzer et al., (136) observed a negative relationship between the 
proximity of the lesion to the hippocampus and response to a naming treatment. Bonilha et 
al., (137) showed that measures of neural network connectivity combined with initial 
behavioral deficit severity accounted for 78% of variance in response to anomia treatment. 
Several small studies identified a relationship between therapy success and integrity of the 
left arcuate fasciculus (138), right arcuate fasciculus (139) and white matter in proximity to 
the hippocampus (136). Further, several fMRI studies have investigated treatment-induced 
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aphasia recovery, predominantly in the chronic stage. Fridriksson (122) identified a 
significant relationship between treatment-induced naming improvements and fMRI activity 
in a both a posterior cluster (including parietal lobe and precuneus) and an anterior cluster 
(including middle frontal gyrus and pars opercularis). Subsequent analyses (140) showed that 
altered activity in perilesional areas was associated with increased naming accuracy, but 
measures of pre-treatment brain activity (as opposed to changes in activity) predicted 
improvement in semantic errors, suggesting additional factors contribute to treatment 
outcome. Resting state FC has also shown potential for understanding and predicting aphasia 
recovery in the subacute and chronic phases (including treatment induced improvements) 
however, larger studies are required to validate this approach (141).  
In summary, in the acute and early subacute stages, the use of structural MRI 
provides insights into the neural basis of language deficits, but there are not sufficient large 
studies demonstrating that these methods clearly improve prediction of recovery or treatment 
response. Functional brain assessments such as via fMRI show potential at the early 
subacute stage for significantly improving prediction of outcome (127), however, this 
approach needs validation. Structural MRI and DTI may forecast recovery at the late 
subacute and chronic stage, suggesting the possible use of these techniques to stratify 
patients for clinical trials, understand therapy mechanism and predict outcome. It should be 
noted that: (1) there is still considerable variability in outcome that is not accounted for by 
these methods, (2) each method uses a unique and complex analysis technique, (3) different 
aphasia treatments may engage unique networks (Table 4D), and (4) detailed studies 
examining the combined utility of anatomical and functional brain measures for predicting 
language recovery are warranted.   
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Conclusions 
How might biomarker data be incorporated into future stroke recovery research? As a 
first point, the term “stroke” is inadequate, as it describes a very heterogeneous group of 
disorders that are unified by a vascular injury, but not by size, location, or impact of injury. 
Biomarkers present a way forward to subgroup or stratify patients in order to reduce variance 
and increase power, allowing for smaller sample sizes (7). Moreover, the final behavioral 
phenotype after stroke can arise from many different biological states, which could result in 
differential therapeutic responses; functional measures are complementary to 
anatomical/injury measures. Thus, a patient exploiting all possible compensatory brain 
mechanisms might have little room to improve, while a similar patient who uses no 
compensatory mechanisms might achieve benefit (142). Furthermore, inclusion of 
appropriate biomarkers may improve the ability to disentangle treatment responders from 
non-responders. 
Clinical trials therefore need to base participant eligibility on more than presence of a 
stroke, or behavioural status. Instead, patient selection should include appropriate 
biomarkers; ideally these will be linked with preclinical methods as well as the biological 
mechanism of the therapy or treatment under investigation. For example, recently a threshold 
was defined whereby no patient in the early and late subacute stage with >63% injury to the 
CST achieved clinically important gains associated with a robotic therapy (27). This result 
highlights the ascendant role that neuroimaging measures need to play in clinical-decision 
making for post-stroke rehabilitation (143). 
A useful example comes from the recent phase III Everest trial (144), which relied on 
behavioural assessments to determine participant eligibility, and ultimately found that 
patients randomized to epidural motor cortex stimulation did not reach the primary efficacy 
endpoint more often than patients in the control group. However, a post hoc analysis of 
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patients randomized to epidural stimulation found that the primary efficacy endpoint was 
reached more often (67%) by those with preserved motor evoked responses upon cortical 
stimulation compared to those lacking a response (27%) (26). Thus, had confirmation of 
physiological integrity of the biological target been an eligibility criterion (as was the case in 
all preclinical studies that were translated to generate this trial), the effect size would have 
been substantially higher and the trial results quite different. We believe that this example is 
highly useful in illustrating the utility of biomarkers in recovery and rehabilitation research 
and expect that the inclusion of biomarkers will enhance future clinical trials. 
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Table 1: Summary of possible brain biomarkers to measure brain structure or function. 
 
Measures of structure/injury: Measures of function: 
• Computed tomography (CT) 
• Diffusion tensor imaging (DTI) 
• Diffusion weighted imaging (DWI) 
• Fluid Attenuation Inversion Recovery 
(FLAIR) 
• Gradient echo and spin echo (GRASE) 
• T1-weighted MRI 
• T2-weighted MRI 
• Proton density-weighted MRI 
• Electroencephalograpy (EEG) 
• Functional magnetic resonance imaging 
(fMRI) 
• Magnetoencephalography (MEG) 
• Magnetic resonance spectroscopy (MRS) 
• Near Infrared Spectroscopy Imaging 
(NIRSI) 
• Positron emission tomography (PET) 
• Resting state magnetic resonance imaging 
(rsMRI) 
• Sensory electroencephalography (sEEG) 
• Transcranial magnetic stimulation (TMS) 
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Table 2: Scope of functional domains considered given existing literature. 
Motor refers to motor outcomes, inclusive of upper and lower limb functions. 
Sensation refers to somatosensation, touch and proprioception. 
Cognition refers to ‘executive functioning’ or ‘cognitive control’, which are umbrella terms 
for sub-processes of selective attention, error monitoring, decision-making memory and 
response inhibition.  
Language refers to spoken language production, auditory language comprehension, and 
global measures of language function (that also include reading and writing).  
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Table 3: Scope for expert consensus biomarker recommendations.  
• Ready to be used in clinical trial means that based on the available evidence it is recommended 
that the biomarker should be included in stroke clinical trials (pilot and feasibility work through to 
phase II/III/IV trials). 
• Development priority refers to biomarkers where there is some evidence in human populations 
with stroke, but questions remain or the evidence is insufficient to support the inclusion of this 
biomarker in clinical trials at present. Predictive data of outcome and/or recovery is needed to 
establish its utility in clinical trials. 
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Table 4: Expert consensus biomarker recommendations  
A) Motor 
Ready to be used in clinical trial. 
• CST indexed by DTI or by lesion overlap in the hyperacute, acute, early and late subacute, 
and chronic phases, which has demonstrated a moderate to strong relationship with 
impairment (outcome and recovery)  
• TMS measure of MEP+ or MEP- of the upper limb to understand and track motor recovery 
up to the late subacute phase and understand the effects of rehabilitation interventions up to 
the chronic phase post-stroke. There is evidence of a strong relationship between impairment 
(outcome and recovery) and MEP status. We recommend that future studies of upper limb 
interventions determine whether patients are MEP+ or MEP- for the purposes of 
stratification.  
 
Developmental priority  
• Lesion location measured in the hyperacute phase. Identifying critical areas damaged that 
could predict recovery or treatment response may be important. Combining location and 
volume of stroke damage using multivariate techniques is the next logical step. 
• Leukoaraiosis and covert lesions in the hyperacute, early and late acute and chronic 
phases require further validation to understand how they impact motor recovery. 
• Accumulate further evidence of the usefulness of MEP+/- in the lower limb. 
• Determining the utility of the laterality index from functional MRI as a predictor of efficacy 
in earlier stages post stroke is a developmental priority.  
• Determine the utility of measures of rsFC and task-based activation and MEG/sEEG to 
predict treatment response in the early subacute, late subacute and chronic stages of 
recovery. 
 
B) Somatosensory 
Ready to be used in clinical trial  
• There are no somatosensory system biomarkers ready for clinical trials.  
 
Developmental priority 
• Understand outcome and predict somatosensory recovery in the acute through to chronic 
stages using: 
o Biologically reliable measures of white matter fibre tract integrity and connectivity 
within and across brain networks e.g. using diffusion-based tractography.  
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o Measures of rsFC, and fMRI activation.  
 
C) Cognition 
Ready to be used in clinical trial  
• There are no biomarkers ready to be used in clinical trials. 
 
Developmental priority 
• Understand outcome and predict recovery in the acute to chronic stages of recovery using 
o Measures of white matter integrity within both lesioned and non-lesioned areas. 
o Measures of rsFC and task-based FC. 
• Predict treatment response in the early subacute, late subacute and chronic stages of recovery 
using measures of rsFC and fMRI activation. 
 
D) Language 
Ready to be used in clinical trials 
• Index structural damage as per PLORAS imaging protocol in the chronic phase of recovery to 
understand outcome and predict recovery. When the PLORAS database is used with an 
individual’s lesion information combined with time post-stroke and speech behaviour it 
provides a strong  predictor of longitudinal aphasia recovery. 
Developmental priority 
• Index structural damage to and integrity of the arcuate fasciculus with diffusion weighted 
imaging in the late subacute and chronic phases of recovery to understand and predict 
outcome. 
• Predict recovery using perfusion CT and MRI in the hyperacute phase. 
• Determine if structural damage predicts therapy or treatment response in the subacute through 
to chronic phases. 
• Predict recovery and treatment response in subacute to chronic phase using measures of task-
based fMRI activation. 
• Explore measures of inter and intra-network connectivity (including rsFC) and multivariate 
connectome-based symptom mapping for prediction of outcome and treatment response. 
 
 
Legend: CST, corticospinal tract; CT, computed tomography; DTI, diffusion tensor imaging; 
FC, functional connectivity; fMRI, functional magnetic resonance imaging; MEP+, motor 
evoked potential present; MEG, magnetoencephalography; MEP-, motor evoked potential 
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absent; MRI, magnetic resonance imaging; PLORAS, Predicting Language Recovery and 
Outcome After Stroke; rsFC, resting state functional connectivity; sEEG, sensory 
electroencephalography. 
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